BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hosseini-hooshyar S, Hajarizadeh B, Bajis S, Law M, Janjua NZ, Fierer DS, Chromy D, Rockstroh JK, Martin TCS, Ingiliz P, Hung C, Dore GJ, Martinello M, Matthews GV. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression. The Lancet HIV 2022;9:e414-27. [DOI: 10.1016/s2352-3018(22)00077-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Marshall AD, Martinello M, Treloar C, Matthews GV. Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study. Int J Drug Policy 2022;109:103828. [PMID: 35994937 DOI: 10.1016/j.drugpo.2022.103828] [Reference Citation Analysis]
2 Garvey L, Cooke GS. Engaging with HCV reinfection to advance microelimination. The Lancet HIV 2022;9:e372-4. [DOI: 10.1016/s2352-3018(22)00128-x] [Reference Citation Analysis]